Dr. Townsend is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce Street, 1 Founders
Philadelphia, PA 19104Phone+1 267-738-3431
Education & Training
- Temple University HospitalFellowship, Nephrology, 1982 - 1984
- Allegheny Health Network Medical Education Consortium (AGH)Residency, Internal Medicine, 1980 - 1982
- Allegheny Health Network Medical Education Consortium (AGH)Internship, Internal Medicine, 1979 - 1980
- Drexel University College of MedicineClass of 1979
Certifications & Licensure
- PA State Medical License 1981 - 2026
- OK State Medical License 1981 - 2017
- TX State Medical License 1988 - 1999
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
- American Society of HypertensionClinical Specialist in Hypertension
- ASCPClinical Pharmacology
Awards, Honors, & Recognition
- Physician of the Year American Heart Association, 2016
Clinical Trials
- Transformative Research in Diabetic Nephropathy Start of enrollment: 2016 Dec 01
Publications & Presentations
PubMed
- Pulse Pressure and Cardiovascular and Kidney Outcomes by Age in the Chronic Renal Insufficiency Cohort (CRIC).Clara J Fischman, Raymond R Townsend, Debbie L Cohen, Mahboob Rahman, Matthew R Weir
American Journal of Hypertension. 2025-01-16 - Progression of Coronary Artery Calcification and Risk of Clinical Events in CKD: The Chronic Renal Insufficiency Cohort Study.Ling Tian, Byron C Jaeger, Julia J Scialla, Matthew J Budoff, Rupal C Mehta
American Journal of Kidney Diseases. 2025-01-01 - Three Ankle-Brachial Index Ranges and Incident CKD in Diabetes: A Goldilocks Perspective on the "Just Right" Range.Houry Puzantian, Raymond R Townsend
American Journal of Kidney Diseases. 2025-01-01
Press Mentions
- FDA Panel Says Risks of Radiofrequency Renal Denervation Device Outweigh BenefitsAugust 25th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: